New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2014
08:56 EDTANIPANI Pharmaceuticals 1.4M share Spot Secondary priced at $31.00
Oppenheimer and Roth Capital acted as joint book running managers for the offering.
News For ANIP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 27, 2015
08:08 EDTANIPANI Pharmaceuticals and Sofgen announce FDA approval of nimodipine capsules
ANI Pharmaceuticals announced that its ANDA collaboration partner Sofgen has received approval from the FDA of the Abbreviated New Drug Application for Nimodipine 30mg Capsules. Trailing twelve-month sales for the product are $25 million, according to IMS Health, with two current competitors. ANI and Sofgen expect to begin shipping to customers this year.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use